Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns 
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface 
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey 
Asian Stocks Slide as Central Bank Decisions and Key Data Keep Investors Cautious 
Oil Prices Rebound as Trump Orders Blockade of Sanctioned Venezuelan Tankers 
Chinese Robotaxi Stocks Rally as Tesla Boosts Autonomous Driving Optimism 
South Korea Warns Weak Won Could Push Inflation Higher in 2025 
China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand 
Bank of Japan Poised for Historic Rate Hike as Inflation Pressures Persist 
Oil Prices Slip in Asia as 2026 Supply Glut Fears and Russia-Ukraine Talks Weigh on Markets 
Asian Currencies Slip as Dollar Strengthens; Indian Rupee Rebounds on Intervention Hopes 
Asian Stocks Slide as AI Valuation Fears and BOJ Uncertainty Weigh on Markets 
Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets 
Japan Exports to U.S. Rebound in November as Tariff Impact Eases, Boosting BOJ Rate Hike Expectations 
Wall Street Futures Slip as Tech Stocks Struggle Ahead of Key US Economic Data 
Starboard Value’s Investment in Kenvue Inc.
Activist hedge fund Starboard Value has taken a "sizeable" stake in Kenvue Inc., according to *The Wall Street Journal*. While the exact percentage of the investment is undisclosed, Starboard is pushing for changes aimed at boosting Kenvue's stock price. Kenvue, which was spun off from Johnson & Johnson in 2023, has seen its stock underperform both its industry peers and the broader market since its debut.
Kenvue’s Strong Consumer Brands
Kenvue boasts several well-known consumer brands, such as Tylenol, Listerine, and Band-Aid. Despite its strong portfolio, Kenvue's stock performance has been relatively muted in 2024, while the S&P 500 has surged by 24%. Starboard believes that these valuable brands are not yet reflected in the company’s current valuation.
Starboard’s Broader Strategy
This is not the first major move by Starboard Value. The hedge fund, led by CEO Jeff Smith, recently acquired a $1 billion stake in pharmaceutical giant Pfizer and has been involved in advocating for changes at tech companies like Salesforce, Autodesk, and Match Group.
